世界のウェアラブルヘルスケア機器市場は、2024年に410億7,000万ドルと評価され、2025年には452億9,000万ドルに達し、2025年から2030年にかけて10.9%の堅調なCAGRで拡大し、期末までに759億8,000万ドルの予測評価額に達すると予想されます。市場の成長は、健康意識の高まり、予防ケアへの移行、高齢化人口における慢性疾患の有病率の増加によって推進されています。
目次
TABLE OF CONTENTS
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Primary sources
2.2.2.2 Key industry insights
2.2.2.3 Key data from primary sources
2.2.2.4 Breakdown of primary interviews
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 Approach 1: Company revenue estimation approach
2.3.1.2 Approach 2: Presentations of companies and primary interviews
2.3.1.3 Approach 3: Primary interviews
2.3.1.4 Growth forecast
2.3.1.5 CAGR projections
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.5.1 STUDY-RELATED ASSUMPTIONS
2.5.2 PARAMETRIC ASSUMPTIONS
2.5.3 GROWTH RATE ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 WEARABLE HEALTHCARE DEVICES MARKET OVERVIEW
4.2 ASIA PACIFIC: WEARABLE HEALTHCARE DEVICES MARKET SHARE, BY DISTRIBUTION CHANNEL AND COUNTRY
4.3 WEARABLE HEALTHCARE DEVICES MARKET, BY KEY COUNTRY
4.4 WEARABLE HEALTHCARE DEVICES MARKET, REGIONAL MIX, 2025 VS. 2030
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising health consciousness and shift toward lifestyle & home-based healthcare
5.2.1.2 Advancements in wearable technology
5.2.1.3 Rising geriatric population and surge in chronic diseases
5.2.1.4 Growing public and private investments
5.2.1.5 Increasing availability of smartphone-based applications and rising adoption of 3G/4G networks
5.2.2 RESTRAINTS
5.2.2.1 Inconsistent regulations across regions
5.2.2.2 Challenges associated with data accuracy, privacy, and interpretation of wearable-generated information
5.2.2.3 Growing data security concerns
5.2.3 OPPORTUNITIES
5.2.3.1 Expansion of AI and 5G applications in medical devices
5.2.3.2 Growing preference for wireless connectivity among healthcare providers
5.2.4 CHALLENGES
5.2.4.1 Patent protection of wearable healthcare devices
5.2.4.2 Challenges due to limited battery life
5.2.4.3 Design and integration challenges in wearable devices
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
5.4 PRICING ANALYSIS
5.4.1 AVERAGE SELLING PRICE TREND OF SMARTWATCHES, BY KEY PLAYER, 2023-2025
5.4.2 AVERAGE SELLING PRICE TREND OF WEARABLE HEALTHCARE DEVICES, BY REGION, 2023-2025
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
5.8 INVESTMENT & FUNDING SCENARIO
5.9 TECHNOLOGY ANALYSIS
5.9.1 KEY TECHNOLOGIES
5.9.1.1 Continuous glucose monitoring (CGM)
5.9.2 COMPLEMENTARY TECHNOLOGIES
5.9.2.1 Closed-loop drug delivery systems
5.9.3 ADJACENT TECHNOLOGIES
5.9.3.1 Telehealth systems
5.10 PATENT ANALYSIS
5.10.1 LIST OF MAJOR PATENTS
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA (HS CODE 901890)
5.11.2 EXPORT DATA (HS CODE 901890)
5.12 KEY CONFERENCES & EVENTS, 2025-2026
5.13 REGULATORY ANALYSIS
5.13.1 REGULATORY LANDSCAPE
5.13.1.1 North America
5.13.1.1.1 US
5.13.1.1.2 Canada
5.13.1.2 Europe
5.13.1.3 Asia Pacific
5.13.1.3.1 China
5.13.1.3.2 Japan
5.13.1.3.3 India
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.14 PORTER'S FIVE FORCES ANALYSIS
5.14.1 THREAT OF NEW ENTRANTS
5.14.2 THREAT OF SUBSTITUTES
5.14.3 BARGAINING POWER OF BUYERS
5.14.4 BARGAINING POWER OF SUPPLIERS
5.14.5 INTENSITY OF COMPETITIVE RIVALRY
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.15.2 BUYING CRITERIA
5.16 IMPACT OF AI ON WEARABLE HEALTHCARE DEVICES MARKET
5.16.1 INTRODUCTION
5.16.2 POTENTIAL OF AI IN WEARABLE HEALTHCARE DEVICES MARKET
5.16.3 AI USE CASES
5.16.4 KEY COMPANIES IMPLEMENTING AI
5.16.5 FUTURE OF AI IN WEARABLE HEALTHCARE DEVICES MARKET
5.17 IMPACT OF 2025 US TARIFFS ON WEARABLE HEALTHCARE DEVICES MARKET
5.17.1 INTRODUCTION
5.17.2 KEY TARIFF RATES
5.17.3 PRICE IMPACT ANALYSIS
5.17.4 KEY IMPACTS ON COUNTRY/REGION
5.17.4.1 US
5.17.4.2 Europe
5.17.4.3 Asia Pacific
5.17.5 IMPACT ON END-USE INDUSTRIES
5.17.5.1 Remote patient monitoring
6 WEARABLE HEALTHCARE DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 SMARTWATCHES
6.2.1 ADVANTAGES SUCH AS SEAMLESS INTEGRATION WITH ATTRACTIVE DISPLAYS TO BOOST DEMAND
6.3 TRACKERS
6.3.1 RISING HEALTH CONCERNS AND CHRONIC DISEASE BURDEN TO FUEL DEMAND FOR FITNESS TRACKERS
6.4 PATCHES
6.4.1 HIGH ACCURACY IN DATA COLLECTION TO DRIVE DEMAND FOR WEARABLE PATCHES
6.5 SMART CLOTHING
6.5.1 ADVANCED CAPABILITIES AND FLEXIBLE DESIGN TO SUPPORT MARKET EXPANSION
7 WEARABLE HEALTHCARE DEVICES MARKET, BY TYPE
7.1 INTRODUCTION
7.2 DIAGNOSTIC & MONITORING DEVICES
7.2.1 VITAL SIGN MONITORING DEVICES
7.2.1.1 Multiparameter trackers
7.2.1.1.1 Real-time monitoring of multiple physiological & biochemical parameters to drive demand
7.2.1.2 ECG/heart rate monitors
7.2.1.2.1 Ability to monitor critical cardiac parameters to drive adoption
7.2.1.3 Blood pressure monitors
7.2.1.3.1 Rising incidence of hypertension to propel market
7.2.1.4 Pulse oximeters
7.2.1.4.1 Rising incidence of respiratory diseases and COPD to boost market growth
7.2.2 GLUCOSE MONITORING DEVICES
7.2.2.1 Technological advancements and embedded wireless systems to drive market growth
7.2.3 SLEEP MONITORING DEVICES
7.2.3.1 Wrist actigraphs
7.2.3.1.1 Increasing focus on actimeter performance to drive market growth
7.2.3.2 Polysomnography devices
7.2.3.2.1 Ability to test multiple vital parameters to support market growth
7.2.4 FETAL MONITORING & OBSTETRIC DEVICES
7.2.4.1 Rising number of preterm births to fuel market growth
7.2.5 NEUROMONITORING DEVICES
7.2.5.1 Enhanced portability and ease of use to boost market growth
7.3 THERAPEUTIC DEVICES
7.3.1 PAIN MANAGEMENT DEVICES
7.3.1.1 Rising emphasis on chronic pain relief to drive growth in wearable pain management devices market
7.3.2 REHABILITATION DEVICES
7.3.2.1 Growing demand for post-surgical home care to drive market expansion
7.3.3 RESPIRATORY THERAPY DEVICES
7.3.3.1 Increasing incidence of COPD to drive demand for respiratory wearables
7.3.4 INSULIN PUMPS
7.3.4.1 Rising awareness about self-monitoring to fuel adoption of wearable insulin delivery systems
8 WEARABLE HEALTHCARE DEVICES MARKET, BY GRADE
8.1 INTRODUCTION
8.2 CONSUMER-GRADE WEARABLE HEALTHCARE DEVICES
8.2.1 WIDESPREAD AVAILABILITY AND AFFORDABILITY TO DRIVE GROWTH OF CONSUMER-GRADE WEARABLES MARKET
8.3 CLINICAL-GRADE WEARABLE HEALTHCARE DEVICES
8.3.1 REGULATORY-APPROVED DEVICES WITH HIGH ACCURACY TO DRIVE MARKET DEMAND
9 WEARABLE HEALTHCARE DEVICES MARKET, BY DISTRIBUTION CHANNEL
9.1 INTRODUCTION
9.2 ONLINE CHANNELS
9.2.1 FACTORS SUCH AS EASY ACCESS AND 24/7 AVAILABILITY TO BOOST MARKET GROWTH
9.3 PHARMACIES
9.3.1 GROWING PREFERENCE FOR TRUSTED, HIGH-QUALITY PRODUCTS TO SUPPORT MARKET EXPANSION
9.4 HYPERMARKETS
9.4.1 EXPANDING RETAIL INFRASTRUCTURE IN EMERGING MARKETS TO DRIVE GROWTH
10 WEARABLE HEALTHCARE DEVICES MARKET, BY APPLICATION
10.1 INTRODUCTION
10.2 GENERAL HEALTH & FITNESS
10.2.1 RISING EMPHASIS ON LIFESTYLE MANAGEMENT TO DRIVE MARKET EXPANSION
10.3 REMOTE PATIENT MONITORING
10.3.1 COST EFFICIENCY AND REMOTE DATA SHARING TO DRIVE MARKET GROWTH
10.4 HOME HEALTHCARE
10.4.1 GROWING ADOPTION OF REAL-TIME MONITORING IN HOME HEALTHCARE TO DRIVE MARKET GROWTH
11 WEARABLE HEALTHCARE DEVICES MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Presence of various federal mandates that encourage adoption of eHealth among healthcare providers to drive market growth
11.2.3 CANADA
11.2.3.1 Increasing number of investments in wearable devices to fuel market growth in Canada
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Growing preference for home monitoring to boost market growth in Germany
11.3.3 UK
11.3.3.1 Increasing incidence of chronic diseases to drive market growth in the UK
11.3.4 FRANCE
11.3.4.1 Growing geriatric population to drive demand for vital sign monitoring devices in France
11.3.5 ITALY
11.3.5.1 Growing adoption of mobile devices among healthcare professionals to support market growth in Italy
11.3.6 SPAIN
11.3.6.1 Initiatives to promote mHealth solutions to support growth of market in Spain
11.3.7 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 CHINA
11.4.2.1 Huge population base using wearable healthcare device to propel market growth
11.4.3 JAPAN
11.4.3.1 Growing geriatric population and rising focus on home monitoring to drive market in Japan
11.4.4 INDIA
11.4.4.1 Rising disposable income levels to enhance consumer access to advanced medical technologies
11.4.5 AUSTRALIA
11.4.5.1 Growing digitalization and increasing preference for home monitoring to boost market growth
11.4.6 NEW ZEALAND
11.4.6.1 Advancing remote care and equity-driven digital health to accelerate wearable device uptake
11.4.7 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Strengthening public digital health systems and expanding remote access to drive wearable healthcare adoption
11.5.3 MEXICO
11.5.3.1 Expanding telemedicine and digital networks to enable wearable device uptake
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 GROWING ADOPTION OF DISRUPTIVE SOLUTIONS TO BOOST DEMAND FOR WEARABLE HEALTHCARE DEVICES IN THIS REGION
11.7 GCC COUNTRIES
11.7.1 RISING FOCUS ON EXPANDING AND IMPROVING HEALTH INFRASTRUCTURE TO DRIVE MARKET
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN WEARABLE HEALTHCARE DEVICES MARKET
12.3 REVENUE ANALYSIS, 2022-2024
12.4 MARKET SHARE ANALYSIS, 2024
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Product footprint
12.5.5.4 Grade footprint
12.5.5.5 Distribution channel footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
12.6.5.1 Detailed list of key startups/SMEs
12.6.5.2 Competitive benchmarking of key startups/SMEs
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.7.1 COMPANY VALUATION
12.7.2 FINANCIAL METRICS
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 OTHER DEVELOPMENTS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 APPLE INC.
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.3.1 Product launches
13.1.1.3.2 Other developments
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 SAMSUNG ELECTRONICS CO., LTD.
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.3.1 Product launches & approvals
13.1.2.3.2 Deals
13.1.2.4 MnM view
13.1.2.4.1 Key strengths
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 ABBOTT
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 Recent developments
13.1.3.3.1 Product approvals
13.1.3.3.2 Deals
13.1.3.4 MnM view
13.1.3.4.1 Key strengths
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses & competitive threats
13.1.4 DEXCOM, INC.
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.3.1 Product launches & approvals
13.1.4.3.2 Deals
13.1.4.3.3 Other developments
13.1.4.4 MnM view
13.1.4.4.1 Key strengths
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 FITBIT INC. (SUBSIDIARY OF ALPHABET INC.)
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.3.1 Product launches
13.1.5.3.2 Other developments
13.1.5.4 MnM view
13.1.5.4.1 Key strengths
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 KONINKLIJKE PHILIPS N.V.
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.6.3.1 Deals
13.1.7 GARMIN LTD.
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.7.3.1 Product launches
13.1.7.3.2 Deals
13.1.8 BOSTON SCIENTIFIC CORPORATION
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.9 OMRON CORPORATION
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.9.3 Recent developments
13.1.9.3.1 Deals
13.1.10 MASIMO
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.10.3 Recent developments
13.1.10.3.1 Product launches & approvals
13.1.10.3.2 Deals
13.1.11 GE HEALTHCARE
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.11.3 Recent developments
13.1.11.3.1 Deals
13.1.11.3.2 Other developments
13.2 OTHER PLAYERS
13.2.1 BIOTRICITY
13.2.2 IRHYTHM TECHNOLOGIES, INC.
13.2.3 CONTEC MEDICAL SYSTEMS CO., LTD.
13.2.4 MEDIBIOSENSE
13.2.5 VITALCONNECT
13.2.6 CYRCADIA HEALTH
13.2.7 EMPATICA INC.
13.2.8 MINTTIHEALTH
13.2.9 BIOBEAT
13.2.10 IHEALTH LABS INC.
13.2.11 VIVALNK, INC.
13.2.12 GENTAG, INC.
13.2.13 AIQ SMART CLOTHING
13.2.14 NONIN
13.2.15 OXITONE
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS